Can We Diagnose Early Melanoma With New Imaging Technologies?
International Journal of Dermatology · 2026
DOI: 10.1111/ijd.70547 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, 2026. Verfasst von Maximilian Deußing und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, LMU University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Early Detection of Cancer, Multimodal Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Multimodal imaging enables risk‐adapted early melanoma diagnosis by integrating dermoscopy, OCT, in vivo RCM, ex vivo RCM, and LC‐OCT. These technologies provide complementary architectural, cellular, and perioperative information, supporting improved diagnostic precision while reducing unnecessary excisions in equivocal melanocytic lesions. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Allergy, LMU University Hospital, LMU Munich, Munich, Germany.
- Department of Dermatology and Allergy, Munich Municipal Hospital, Munich, Germany.
ORCID-Profile: Maximilian Deußing
Zitieren
APA
Deußing, M., & Hartmann, D. (2026). Can We Diagnose Early Melanoma With New Imaging Technologies?. International Journal of Dermatology. https://doi.org/10.1111/ijd.70547
Vancouver
Deußing M, Hartmann D. Can We Diagnose Early Melanoma With New Imaging Technologies?. International Journal of Dermatology. 2026. doi:10.1111/ijd.70547
BibTeX
@article{Deuing2026,
author = {Deußing, Maximilian and Hartmann, Daniela},
title = {Can We Diagnose Early Melanoma With New Imaging Technologies?},
journal = {International Journal of Dermatology},
year = {2026},
doi = {10.1111/ijd.70547}
}
EUVIMED